ROIV

#573
Roivant Sciences Ltd. Common Shares
29.3935 USD
+1.53%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
29.2350
29.4200
Rango anual
18.2700
30.3300
Cambio diario
+1.53%
Variación mensual
+3.15%
Variación en los últimos 6 meses
+60.53%
Cambio anual
+60.53%
Cierres anteriores
28.9500
Abrir
29.3300
Bid
Ask
Mínimo
29.2350
High
29.4200
Volumen
310
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 21.037 B
  • Employee 750
  • Founded 2014
  • CEO Matt Gline
  • Website www.roivant.com
  • Headquarter Bermuda
  • FIGI N/A
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-42.04
Relación precio/flujo de caja
251.93

Roivant Sciences Ltd

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

Noticias